generic drugs
Ozempic Launches in India: Novo Nordisk's Diabetes and Weight Loss Drug Enters World's Second-Largest Diabetes Market
Dec 12, 2025 05:46 pm CST
Novo Nordisk has introduced Ozempic to the Indian market, pricing the diabetes medication at Rs 8,800-11,175 monthly across three dosages. The strategic launch targets India's significant diabetic population before generic competitors arrive in 2026. Beyond blood sugar control, Ozempic offers weight loss benefits and reduced cardiovascular risks, but remains prescription-restricted for medical use only.
Trump Administration Drops Plans to Impose Tariffs on Generic Drugs: A Positive Development for Indian Pharmaceutical Industry
Oct 10, 2025 06:25 pm CST
The Trump administration has decided against implementing tariffs on generic drugs imported from foreign countries, providing relief to both Indian pharmaceutical manufacturers, who supply nearly half of all generic prescriptions in the US market, and American consumers who depend on affordable medications. This decision comes after President Trump had previously announced 100 percent tariffs on branded drugs starting October 1.
Indian Pharma Largely Protected from Trump's 100% Tariffs on Imported Drugs
Sep 26, 2025 04:11 pm CST
President Trump's new 100% tariffs on imported branded pharmaceuticals may have minimal impact on India's drug industry as most major Indian pharma companies already operate manufacturing facilities in the US. With Indian exports to America primarily consisting of generic medications worth $10.5 billion annually, companies like Cipla, Dr Reddy's, and Biocon are strategically positioned to navigate these trade restrictions while stock markets respond cautiously to the announcement.
Trump's 100% Pharmaceutical Tariffs: Potential Impact on India's $8.7 Billion US Drug Exports
Sep 26, 2025 01:18 pm CST
US President Donald Trump has announced 100% tariffs on branded and patented pharmaceutical imports starting October 1, 2025, unless companies build manufacturing facilities in America. This decision could significantly impact India's pharmaceutical sector, which exported $8.7 billion in medicines to the US in FY24, representing 31% of India's total pharma exports. With Indian companies supplying 45% of US generic drugs, both nations face potential consequences including price increases and supply disruptions.
Trump Announces 100% Tariff on Pharmaceutical Imports Unless Companies Build US Manufacturing Plants
Sep 26, 2025 11:42 am CST
President Donald Trump has announced 100% tariffs on pharmaceutical imports effective October 1, 2025, with exemptions for companies actively constructing manufacturing facilities in the US. The policy could significantly impact India's pharmaceutical sector, which exports over $3.6 billion in products to the US annually. This move follows recent 50% tariffs imposed on India for purchasing Russian oil, as bilateral trade negotiations continue.